Acute promyelocytic leukemia: a paradigm for oncoprotein-targeted cure

PP Pandolfi, Z Chen - Cancer cell, 2017 - cell.com
Recent clinical trials have demonstrated that the immense majority of acute promyelocytic
leukemia (APL) patients can be definitively cured by the combination of two targeted …

Acute promyelocytic leukemia: a history over 60 years—from the most malignant to the most curable form of acute leukemia

X Thomas - Oncology and therapy, 2019 - Springer
Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia (AML)
that is cytogenetically characterized by a balanced reciprocal translocation between …

Functional analysis of Cullin 3 E3 ligases in tumorigenesis

J Cheng, J Guo, Z Wang, BJ North, K Tao, X Dai… - … et Biophysica Acta (BBA …, 2018 - Elsevier
Abstract Cullin 3-RING ligases (CRL3) play pivotal roles in the regulation of various
physiological and pathological processes, including neoplastic events. The substrate …

Characterization of the plant homeodomain (PHD) reader family for their histone tail interactions

K Jain, CS Fraser, MR Marunde, MM Parker… - Epigenetics & …, 2020 - Springer
Background Plant homeodomain (PHD) fingers are central “readers” of histone post-
translational modifications (PTMs) with> 100 PHD finger-containing proteins encoded by the …

In-Depth Proteomic Analysis of Paraffin-Embedded Tissue Samples from Colorectal Cancer Patients Revealed TXNDC17 and SLC8A1 as Key Proteins Associated …

A Montero-Calle, M Garranzo-Asensio… - Journal of Proteome …, 2024 - ACS Publications
A deeper understanding of colorectal cancer (CRC) biology would help to identify specific
early diagnostic markers. Here, we conducted quantitative proteomics on FFPE healthy …

Cellular hierarchy insights reveal leukemic stem-like cells and early death risk in acute promyelocytic leukemia

W Jin, Y Dai, L Chen, H Zhu, F Dong, H Zhu… - Nature …, 2024 - nature.com
Acute promyelocytic leukemia (APL) represents a paradigm for targeted differentiation
therapy, with a minority of patients experiencing treatment failure and even early death. We …

PHRF1 promotes the class switch recombination of IgA in CH12F3-2A cells

JY Lee, NL Chou, YR Yu, HA Shih, HW Lin, CK Lee… - Plos one, 2023 - journals.plos.org
PHRF1 is an E3 ligase that promotes TGF-β signaling by ubiquitinating a homeodomain
repressor TG-interacting factor (TGIF). The suppression of PHRF1 activity by PML-RARα …

TGIF 1 functions as a tumor suppressor in pancreatic ductal adenocarcinoma

P Parajuli, P Singh, Z Wang, L Li, S Eragamreddi… - The EMBO …, 2019 - embopress.org
A prominent function of TGIF 1 is suppression of transforming growth factor beta (TGF‐β)
signaling, whose inactivation is deemed instrumental to the progression of pancreatic ductal …

A novel network pharmacology approach for leukaemia differentiation therapy using Mogrify®

LM Lee, EG Christodoulou, P Shyamsunder, BJ Chen… - Oncogene, 2022 - nature.com
Acute myeloid leukaemia (AML) is a rapidly fatal blood cancer that is characterised by the
accumulation of immature myeloid cells in the blood and bone marrow as a result of blocked …

All-trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells

XZ Liu, J Chen, SH Yu, L Yan, HZ Guo, JM Dai… - Cell Death & …, 2017 - nature.com
All-trans retinoic acid (ATRA) and/or arsenic trioxide (ATO) administration leads to
granulocytic maturation and/or apoptosis of acute promyelocytic leukemia (APL) cells mainly …